Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuroone Medical Technologies (NMTC) Other Operating Expenses (2016 - 2026)

Neuroone Medical Technologies filings provide 8 years of Other Operating Expenses readings, the most recent being $415795.0 for Q1 2026.

  • On a quarterly basis, Other Operating Expenses rose 140.51% to $415795.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $415795.0, a 76.19% decrease, with the full-year FY2024 number at $1.4 million, changed N/A from a year prior.
  • Other Operating Expenses hit $415795.0 in Q1 2026 for Neuroone Medical Technologies, up from $172882.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $1.4 million in Q3 2024 to a low of $170042.0 in Q4 2024.
  • Median Other Operating Expenses over the past 3 years was $294338.5 (2025), compared with a mean of $540505.0.
  • The widest YoY moves for Other Operating Expenses: up 140.51% in 2026, down 140.51% in 2026.
  • Neuroone Medical Technologies' Other Operating Expenses stood at $170042.0 in 2024, then rose by 1.67% to $172882.0 in 2025, then skyrocketed by 140.51% to $415795.0 in 2026.
  • The last three reported values for Other Operating Expenses were $415795.0 (Q1 2026), $172882.0 (Q1 2025), and $170042.0 (Q4 2024) per Business Quant data.